TGFbeta 1 receptor kinase inhibitor (Merck Serono)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameTGFbeta 1 receptor kinase inhibitor (Merck Serono)
Drug Alias NameTGFbeta type 1 receptor kinase inhibitor (Merck Serono)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta receptor 1 inhibitors
TargetsTransforming growth factor beta receptor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, Germany
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A